SCHEMBL21983715

SCHEMBL21983715

Cc1ccc2cc(C)n(C3COC3)c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CYP11B2 P19099 2/20 0.33
▸ CYP11B1 P15538 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ RPS6KB1 P23443 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ GRM4 Q14833 1/20 0.30
▸ HTR2A P28223 1/20 0.30
▸ HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21983714 0.84 CYP11B2 (0.43) CYP2A6CYP1A2MAPTRXFP1CHRM2
SCHEMBL21983915 0.81 PRKACA (0.42) CYP2A6CYP1A2MAPTRXFP1CYP11B2
SCHEMBL21983718 0.78 IDH1 (0.33) CYP2A6CYP1A2MAPTRXFP1CYP11B2
SCHEMBL21983723 0.76 CHRM2 (0.35) CYP2A6CYP1A2MAPTRXFP1CHRM2
SCHEMBL21983722 0.75 HTR6 (0.34) MAPTRXFP1CHRM2CHRM4CHRM5
SCHEMBL18960379 0.72 TLR8 (0.45) MAPTCYP11B2KDM4EPRKACARPS6KB1
SCHEMBL20116574 0.71 PDE1B (0.40) CYP1A2CHRM2CHRM1CHRM3CYP11B2
SCHEMBL12717012 0.70 HTR3A (0.35) —
SCHEMBL24159543 0.70 MCHR1 (0.32) CYP2A6CYP1A2MAPTRXFP1KDM4E
SCHEMBL21983720 0.70 MCHR1 (0.32) CYP2A6CYP1A2MAPTRXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3647311-B1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2023-11-01 — — EP disclosed
EP-3932404-A1 METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS Beijing Tide Pharmaceutical Co., Ltd. (CN) 2022-01-05 — — EP disclosed
EP-3647311-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2020-05-06 — — EP disclosed
Send feedback